Evolus Stock (NASDAQ:EOLS)
Previous Close
$9.27
52W Range
$8.67 - $17.82
50D Avg
$9.85
200D Avg
$12.42
Market Cap
$591.89M
Avg Vol (3M)
$1.01M
Beta
0.99
Div Yield
-
EOLS Company Profile
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.